AzTrials
AzTrials

Carotid Artery DiseaseNCT05654935

Telerobotic Ultrasound for Carotid Imaging - Feasibility Study

An observational study of Carotid Artery Disease and Atherosclerosis, run by Rush University Medical Center.

Withdrawn

Withdrawn. The study stopped before anyone enrolled.

Official record

Search all trials

Trial summary

In this proposal, the investigators will demonstrate the feasibility and noninferiority of telerobotic ultrasonography as compared to traditional manual acquisition in performing a limited carotid Duplex examination and in carotid plaque detection. Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
What is being tested?
Ultrasound for Carotid Arteries and Telerobotic Ultrasound for Carotid Arteries
Type of treatment
Surgery or procedure
How many people
0 participants
Where
No sites listed yet
Study dates
26 Mar 2014to 25 Mar 2016
Phase
Observational

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Study population: The study aims will be realized in two separate populations: 1. Cohort A: Includes 26 healthy volunteers >18 years of age. 2. Cohort B: Includes 100 patients ≥ 60 years of age without known carotid artery disease. These patients will be recruited from patients scheduled to receive a clinically indicated cardiac stress test or echocardiogram in the noninvasive cardiac testing area at Rush University Medical Center (Chicago, IL). Patients will be approached regarding their interest in participating in the proposed investigation while waiting for their

Who may be able to join

  • Healthy volunteer
  • >18 years of age
  • Signed informed consent

Who cannot join

  • Prior stroke or transient ischemic attack
  • Prior heart attack.
  • Prior angioplasty/stent of the heart artries
  • Prior bypass surgery of the heart
  • Known history of peripheral arterial disease claudication Peripheral arterial revascularization
  • known history of carotid artery stenosis
  • known history of carotid artery stenosis
  • known history carotid artery dissection

About this study

In this proposal, the investigators will demonstrate the feasibility and noninferiority of telerobotic ultrasonography as compared to traditional manual acquisition in performing a limited carotid Duplex examination and in carotid plaque detection.

Read the detailed description

BACKGROUND

Ultrasonography is an inexpensive, noninvasive, radiation-free diagnostic tool that is indispensable in modern medicine. Carotid intima-media thickness (IMT) and carotid atherosclerotic plaque detection have been powerful screening tools for identifying patients at risk for cardiovascular events; including myocardial infarction, cardiac death, and stroke. The need for trained sonographers by the patient side to perform quality ultrasound studies has limited the accessibility to this imaging tool, both in terms of location and time of day. Robotic arms controlled remotely over the internet, by trained sonographers, can potentially provide easier and more ubiquitous access to ultrasonography in and outside traditional medical facilities, including remote villages in underdeveloped countries, disaster areas, battle zones, etc. In this proposal, the investigators will demonstrate the feasibility and noninferiority of telerobotic ultrasonography as compared to traditional manual acquisition in performing a limited carotid Duplex examination and in carotid plaque detection.

HYPOTHESIS:

Telerobotic ultrasound performed by an experienced sonographer over the Internet produces diagnostic images with quality similar to manual conventional imaging.

AIMS:

  1. Telerobotic ultrasonography produces diagnostic images of the carotid arteries at a rate that is non-inferior to those obtained using standard manual acquisition.
  2. Telerobotic ultrasonography can detect carotid atherosclerotic plaques at a rate that is non-inferior to the gold standard of manual acquisition.

IMPLICATIONS:

Realizing our study aims could mark a new era in ultrasonography. There are wide applications for telerobotic carotid ultrasonography in atherosclerosis screening. Furthermore, establishing the noninferiority of telerobotic carotid ultrasonography acquisition will provide a rationale for further studies in telerobotic ultrasonography, including echocardiography. This in turn has even wider clinical applications such as emergency studies in hospitals during weekends and after-hours. In addition, this could pave the way for use in disaster areas and battle zones where expert sonographers may not be available on-site.

Being tested
Ultrasound for Carotid Arteries, Telerobotic Ultrasound for Carotid Arteries
Medical subject headings
Carotid Artery Diseases, Atherosclerosis, Plaque, Atherosclerotic, Arteriosclerosis, Vascular Diseases, Arterial Occlusive Diseases, Stroke, Death

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Ultrasound for Carotid ArteriesRadiation

    Also called Carotid Ultrasound, Ultrasonography

    Cohort A: each subject will undergo two manual ultrasound image acquisitions by two different registered vascular sonographers who will be blinded to one another's images and findings.

    Cohort B: each subject in Cohort B will undergo one manual ultrasound acquisition conducted at Rush University Medical Center.

  • Telerobotic Ultrasound for Carotid ArteriesRadiation

    Also called Carotid Ultrasound, Telerobotic Ultrasonography

    Cohort A: each subject will undergo two separate telerobotic acquisitions, in which the robotic arm will be controlled by two separate sonographers from Mount Sinai Medical Center (New York, NY). The sonographers controlling the robotic arm will be blinded to one another's images and to the images from the manual acquisition.

    Cohort B: each subject will undergo one telerobotic ultrasound (in random sequence with the manual acquisition also performed for this cohort) acquired by a separate technologist than the technologist that acquired the subject's manual ultrasound. This acquisition will be conducted at Rush University Medical Center by a technologist blinded to the images of the manual acquisition technologist. Robotic acquisition will be manipulated from a different building at Rush University Medical Center using a broadband cellular internet signal (rather than the institutional intranet).

Study groups in NCT05654935
Study groupRoleWhat they receive
Cohort AIncludes 26 healthy volunteers >18 years of age without history of stroke or transient ischemic attack, coronary artery disease (prior myocardial infarction, typical angina, prior percutaneous coronary revascularization, and prior coronary bypass graft surgery), and peripheral arterial disease (claudication, peripheral arterial revascularization stenting of bypass surgery). Subjects will be recruited using advertisement flyers and emails.
Receives: Radiation: Ultrasound for Carotid Arteries; Radiation: Telerobotic Ultrasound for Carotid Arteries
Cohort BIncludes 100 subjects ≥ 60 years of age without known carotid artery disease. These subjects will be recruited from patients scheduled to receive a clinically indicated cardiac stress test or echocardiogram in the noninvasive cardiac testing area at Rush University Medical Center (Chicago, IL).
Receives: Radiation: Ultrasound for Carotid Arteries; Radiation: Telerobotic Ultrasound for Carotid Arteries

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Diagnostic Quality of Telerobotic Ultrasound.

    Gray scale examination of the right and left carotid arteries in 3 views: short axis view of the common carotid artery, long axis view of carotid bifurcation, and short axis view post bifurcation. Images will be analyzed for:

    1. Diagnostic image quality (diagnostic vs. non-diagnostic quality) by 2 reviewers blinded to image acquisition modality (manual vs. telerobotic).
    2. Image quality graded on a scale from 1 to 4 by the same two reviewers as 1) poor/non-diagnostic; 2) fair; 3) acceptable; 4) good/excellent.

    Evaluation for diagnostic quality will be performed by two independent observers who will be blinded to the modality of image acquisition. Disagreement between observers will be resolved by a third blinded observer.

    Measured: 3 months

Secondary outcomes (2)
  1. Carotid Intima-Media Thickness (CIMT) Measurement

    The subjects will be evaluated for the presence or absence of carotid artery atherosclerotic plaques. Each carotid artery (left and right) will be treated as an independent subject. Agreement analysis in the diagnosis of carotid artery plaques, between manual and telerobotic acquisition, will be performed. Identification of carotid artery plaques will be performed by two independent observers. Disagreements will be resolved by a third blinded observer.

    Measured: 3 months

  2. Subject Experience with Manual vs. Telerobotic Ultrasound

    Subject experience with each imaging technique (manual vs. telerobotic) will be determined by a simple questionnaire, as follows:

    1. How did the subject feel during the examination? Comfortable; fairly comfortable; somewhat uncomfortable; very uncomfortable.
    2. Would the subject have this test again in the future? Definitely, probably; probably not, definitely not.

    Measured: 3 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted16 Dec 2022
  2. Study start26 Mar 2014
  3. Primary completion25 Mar 2015
  4. Study completion25 Mar 2016

Why it stopped: Failure to procure funding and technical logistics

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
0 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05654935
Sponsor's protocol ID
13090301-IRB01
Status last verified
Jan 2023
First submitted
8 Dec 2022
Last updated
10 Jan 2023
Results posted
No
Data monitoring committee
No

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in